Sage Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Sage Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q4 2024.
  • Sage Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2024 was 61.4M shares, a 2.19% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 61.4M +1.31M +2.19% Dec 31, 2024 10-K 2025-02-11
Q3 2024 61.2M +1.21M +2.01% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 60.9M +1.1M +1.84% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 60.2M +420K +0.7% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 60M +535K +0.9% Dec 31, 2023 10-K 2025-02-11
Q3 2023 60M +474K +0.8% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 59.8M +407K +0.69% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 59.8M +696K +1.18% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 59.5M +572K +0.97% Dec 31, 2022 10-K 2024-02-14
Q3 2022 59.5M +661K +1.12% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 59.4M +618K +1.05% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 59.1M +659K +1.13% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 58.9M +629K +1.08% Dec 31, 2021 10-K 2023-02-16
Q3 2021 58.8M +6.81M +13.1% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 58.8M +6.84M +13.2% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 58.4M +6.49M +12.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 58.3M +6.43M +12.4% Dec 31, 2020 10-K 2022-02-24
Q3 2020 52M +207K +0.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 51.9M +466K +0.91% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 51.9M +884K +1.73% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 51.9M +4.99M +10.6% Dec 31, 2019 10-K 2021-02-24
Q3 2019 51.8M +4.99M +10.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 51.5M +4.87M +10.4% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 51M +4.58M +9.85% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 46.9M +4.89M +11.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 46.8M +9.31M +24.8% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 46.6M +9.18M +24.5% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 46.5M +9.15M +24.5% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 42M +4.78M +12.8% Dec 31, 2017 10-K 2019-02-19
Q3 2017 37.5M +360K +0.97% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 37.4M +5.35M +16.7% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 37.3M +5.27M +16.4% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 37.2M +8.4M +29.1% Dec 31, 2016 10-K 2018-02-22
Q3 2016 37.2M +8.38M +29.1% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 32.1M +3.45M +12% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 32M +6.34M +24.7% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 28.8M +3.2M +12.5% Dec 31, 2015 10-K 2017-02-24
Q3 2015 28.8M +3.2M +12.5% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 28.6M +26.9M +1570% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 25.7M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 25.6M +24M +1479% Dec 31, 2014 10-K 2016-02-29
Q3 2014 25.6M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 1.71M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 1.62M Dec 31, 2013 10-K 2015-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.